ADAY

This brand name is authorized in Nigeria.

Active ingredients

The drug ADAY contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 8VZV102JFY - FLUCONAZOLE
 

Fluconazole is a triazole antifungal agent. Its primary mode of action is the inhibition of fungal cytochrome P-450-mediated 14 alpha-lanosterol demethylation, an essential step in fungal ergosterol biosynthesis.

 
Read more about Fluconazole
2
UNII J2KLZ20U1M - AZITHROMYCIN ANHYDROUS
 

Azithromycin is a macrolide antibiotic belonging to the azalide group. The molecule is constructed by adding a nitrogen atom to the lactone ring of erythromycin A. The mechanism of action of azithromycin is based upon the suppression of bacterial protein synthesis by means of binding to the ribosomal 50S sub-unit and inhibition of peptide translocation.

 
Read more about Azithromycin
3
UNII R3459K699K - SECNIDAZOLE
 

Secnidazole is a nitroimidazole antimicrobial drug that displays selectivity against many anaerobic Gram-positive and Gram-negative bacteria and protozoa.

 
Read more about Secnidazole

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
B4-0434 Kit Aday Kit KIT 150 mg; 1 g; 1 g 1 x 4's Film coated and uncoated Tablets. Secnidazole: White colour oblong shaped film coated tablet with scored in the middle on one side. Azithromycin: Pink coloured oblong shaped film coated tablets and scored in the middle on the side Fluconazole: Pink colour circular biconvex uncoated tablet and plain on both sides 29/03/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
J02AC01 Fluconazole J Antiinfectives for systemic use → J02 Antimycotics for systemic use → J02A Antimycotics for systemic use → J02AC Triazole and tetrazole derivatives
Discover more medicines within J02AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database B4-0434

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.